Xiaolei Yang Selected Research

Therapeutics

11/2023	Sinus node dysfunction and stroke risk: a systematic review and meta-analysis.
3/2023	Integration of pharmacodynamics, network pharmacology and metabolomics to elucidate effect and mechanism of Artemisia capillaris Thunb. in the treatment of jaundice.
1/2022	Atrial cardiomyopathy markers and new-onset atrial fibrillation risk in patients with acute myocardial infarction.
1/2022	Postmenopausal Women with Breast, Endometrial, and Ovarian Cancers Have an Increased Risk for Cardiovascular Conditions prior to Active Endocrine Therapy.
9/2020	Medication therapy strategies for the coronavirus disease 2019 (COVID-19): recent progress and challenges.
1/2020	Doxorubicin contributes to thrombus formation and vascular injury by interfering with platelet function.
1/2019	Efficacy and Safety of Direct Oral Anticoagulants for Secondary Prevention of Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies.
11/2017	Reversible severe fatty liver induced by capecitabine: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaolei Yang Research Topics

Disease

11	Atrial Fibrillation 12/2023 - 01/2019
10	Neoplasms (Cancer) 12/2023 - 03/2017
9	Inflammation (Inflammations) 01/2022 - 01/2019
7	Hypertension (High Blood Pressure) 01/2022 - 01/2017
7	Atherosclerosis 01/2021 - 01/2011
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2018
5	Fibrosis (Cirrhosis) 01/2022 - 12/2020
4	Poliomyelitis (Polio) 12/2022 - 01/2019
4	Thrombosis (Thrombus) 02/2021 - 03/2017
3	Breast Neoplasms (Breast Cancer) 12/2023 - 11/2017
3	Insulin Resistance 01/2023 - 01/2022
3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 08/2014
3	Autism Spectrum Disorder 01/2022 - 01/2018
3	Atrial Remodeling 01/2022 - 12/2020
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2020
2	Jaundice (Icterus) 03/2023 - 01/2022
2	Hepatitis A (Hepatitis, Infectious) 12/2022 - 01/2021
2	Lung Neoplasms (Lung Cancer) 03/2022 - 10/2015
2	Diabetes Mellitus 01/2022 - 01/2022
2	Cardiac Arrhythmias (Arrythmia) 01/2022 - 01/2022
2	Myocardial Infarction 01/2022 - 01/2022
2	Hyperuricemia 01/2022 - 01/2019
2	Acute Coronary Syndrome 01/2022 - 01/2021
2	Heart Failure 01/2022 - 01/2021
2	Hypertrophy 01/2022 - 01/2022
2	Cardiomegaly (Heart Hypertrophy) 01/2022 - 06/2019
2	Cardiotoxicity 01/2022 - 06/2019
2	Body Weight (Weight, Body) 01/2022 - 01/2022
1	Rheumatoid Arthritis 01/2024
1	Stroke (Strokes) 11/2023
1	Tendinopathy (Tendonitis) 02/2023
1	Congenital Abnormalities (Deformity) 02/2023
1	Pain (Aches) 02/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2023
1	Hepatitis B 12/2022
1	Sepsis (Septicemia) 07/2022
1	Lung Injury 07/2022
1	Septic Shock (Toxic Shock Syndrome) 07/2022

Drug/Important Bio-Agent (IBA)

12	Uric Acid (Urate)IBA 01/2022 - 01/2018
6	Biomarkers (Surrogate Marker)IBA 03/2023 - 01/2019
5	VaccinesIBA 12/2022 - 01/2019
4	Messenger RNA (mRNA)IBA 03/2022 - 01/2011
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2023 - 01/2019
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 01/2022
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2022
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 06/2019
3	LipidsIBA 01/2022 - 01/2021
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2021
3	Apolipoproteins E (ApoE)IBA 01/2020 - 01/2011
3	ApolipoproteinsIBA 01/2020 - 01/2011
2	AnticoagulantsIBA 12/2023 - 01/2019
2	FlavonoidsIBA 03/2023 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
2	Blood Glucose (Blood Sugar)IBA 01/2023 - 01/2022
2	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 12/2022 - 01/2021
2	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2022
2	AntioxidantsIBA 01/2022 - 01/2022
2	AngiotensinsIBA 01/2022 - 01/2017
2	Insulin (Novolin)FDA Link 01/2022 - 01/2022
2	HomocysteineIBA 01/2022 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2020
2	PolymersIBA 11/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 08/2021 - 01/2020
2	oxidized low density lipoproteinIBA 01/2021 - 01/2020
2	Clopidogrel (Plavix)FDA Link 12/2020 - 01/2020
2	c-Mer Tyrosine KinaseIBA 01/2020 - 01/2020
1	Biosimilar PharmaceuticalsIBA 01/2024
1	N- methyl- N- 2- (methylsulfinyl)ethylpropionic acid amide (NMPA)IBA 01/2024
1	tocilizumab (atlizumab)FDA Link 01/2024
1	Methotrexate (Mexate)FDA LinkGeneric 01/2024
1	Warfarin (Coumadin)FDA LinkGeneric 12/2023
1	Dabigatran FDA Link 12/2023
1	RivaroxabanIBA 12/2023
1	Bile Acids and Salts (Bile Acids)IBA 03/2023
1	12- (4'- azido- 2'- nitrophenoxy)dodecanoyl- coenzyme AIBA 03/2023
1	Glutathione (Reduced Glutathione)IBA 03/2023
1	AcidsIBA 03/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2023
1	PantetheineIBA 03/2023
1	Terpenes (Terpenoids)IBA 03/2023
1	isothiocyanic acidIBA 03/2023
1	Glycocholic AcidIBA 03/2023
1	ChromonesIBA 03/2023
1	Taurocholic Acid (Sodium Taurocholate)IBA 03/2023
1	dapagliflozinIBA 01/2023
1	Hepatitis A AntibodiesIBA 12/2022
1	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 12/2022
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 12/2022
1	esmolol (Brevibloc)FDA LinkGeneric 07/2022

Therapy/Procedure

8	Therapeutics 11/2023 - 11/2017
3	Drug Therapy (Chemotherapy) 01/2023 - 02/2021
2	Myocardial Revascularization 01/2022 - 01/2021
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 11/2021 - 03/2020
1	Intravenous Infusions 01/2024
1	Debridement 02/2023
1	Sutures (Suture) 02/2023
1	Braces 02/2023
1	Immunotherapy 01/2023
1	Precision Medicine 01/2023
1	Resuscitation 07/2022